首页 >> 新闻动态 >> 学术活动

学术活动

AAV vector development for human gene therapy of Hemophilia A

发表日期:2017-09-18来源:放大 缩小

题目:AAV vector development for human gene therapy of Hemophilia A

主讲人:Dr. Weidong Xiao professor in temple university, America

时间:2017922, 星期五 上午10:00 – 12:30

地点:广州生物医药与健康研究院 A326

主持人:陈凌 研究员

主讲人简介:Dr. Weidong Xiao qualified in chemistry from University of Sci. and Tec. of China and obtained a PhD in Molecular Virology from University of North Carolina. Latter in 1996,he became a Postdoctoral Fellow of the Institute for Human Gene Therapy University of Pennsylvania, Philadelphia. He is now a professor of the temple universityAmerica, and an assistant professor in Institute of Molecular Medicine of Huaqiao University, China. He is the first one in finding the decoded gene sequence of type AAV and constructing the vector of type AAV for applying. Dr. Xiao is a famous professor in virus vector and gene engineering. His research achievement had been published in several international academic journals, such as PNASJournal of VirologyHepatologyMolecular TherapyBlood and so on. He also owns several American patents invention.
附件: